Search

The senescence-accelerated mouse develops normally until 5-6 months of age and then displays rapid and irreversible advancement of senescence manifesting as clinical signs and gross lesions. To clarify the effect of lactic acid bacteria on the physiological changes with increasing age, heat-killed Lactococcus lactis G50 was administered to 1-month-old senescence-accelerated-prone mouse (SAMP)6 mice for 11 months, a senescence-accelerated mouse strain that develops senile osteoporosis. Mice fed G50 gained more weight than the control mice (not fed G50) during the feeding experiment. Faecal IgA levels in the mice fed G50 at 3 months were higher than those of the control mice but decreased to control levels with increasing age. The numbers of viable cells of Bacteroides sp., Lactobacillus sp., Staphylococcus sp., Enterococcus/Streptococcus sp. and Enterobacteriaceae sp. in faeces were similar for mice fed the G50 and control diets at any age, but strain G50 suppressed the intestinal growth of H2S-producing bacteria. Bone density of the thigh bone did not differ between aged G50 and control mice. Strain G50 would be a beneficial bacterium for the enhancement of intestinal immunity during youth and to suppress the growth of harmful intestinal bacteria. The applicability of strain G50 for the food and animal industries has been proposed in the present study.

The effects of oral administration of a lactococcal strain on physiological changes associated with ageing were investigated using senescence-accelerated mice (SAM). SAM develop normally, but then show an early onset and irreversible advancement of senescence. SAMP6 is a SAM strain that develops osteoporosis with ageing. Oral administration of heat-killed Lactococcus lactis subsp. cremoris H61 (strain H61) to aged SAMP6 mice was associated with reduced bone density loss, a suppression of incidence of skin ulcers and reduced hair loss, compared with controls. Spleen cells from mice fed strain H61 produced more interferon-gamma and IL-12 than those from control mice, suggesting that administration of strain H61 altered immune responses. The numbers of viable cells of Bifidobacterium sp., Bacteroides sp. and Enterococcus sp. in faeces were similar for mice fed the strain H61 and control diets, but counts for Staphylococcus sp. were significantly lower (P < 0.05) in mice fed strain H61. Mice fed strain H61 had similar serum concentrations of thiobarbituric acid-reactive substances as in controls, indicating a lack of effect on lipid peroxidation status. Administration of living cells of strain H61 or fermented milk containing strain H61 was also associated with a suppression of incidence of skin ulcers and reduced hair loss. These results indicate that oral administration of strain H61 has the potential to suppress some of the manifestations associated with ageing.

The molecular mechanisms of strain-specific probiotic effects and the impact of the oral administration of probiotic strains on the host’s gene expression are not yet well understood. The aim of this study was to investigate the strain-specific effects of probiotic strain intake on gene expression in the murine small intestine. Two distinct strains of lactic acid bacteria, Lactobacillus rhamnosus GG (GG) and Lactococcus lactis subsp. lactis C59 (C59), were orally administered to BALB/c mice, daily for 2 weeks. The total RNA was isolated from the upper (including the duodenum) and lower (the terminal ileum) small intestine, and gene expression was assessed by microarray analysis. The data revealed (1) oral administration of C59 and GG markedly down-regulated the expression of genes encoding fibrinogen subunits and plasminogen in the upper small intestine; (2) administration of more than 1 × 107 CFU/day of GG changed the gene expression of the host ileum. (3) strain- and dose-related effects on various GO biological processes; and (4) enrichment for B cell-related Gene Ontology terms among up-regulated genes in the terminal ileum of mice administered the 1 × 109 CFU/day of GG. The distinct effects of GG and C59 on gene expression in the intact small intestine provide clues to understand how the health beneficial effects of specific strains of probiotic bacteria are mediated by interactions with intestinal cells. [ABSTRACT FROM AUTHOR]

Attachment of lactic acid bacteria to the mucosal surface of the gastrointestinal tract is a major property of probiotics. Here, we examined the ability of 21 lactic acid bacterial strains isolated from traditional fermented milk products in Mongolia to adhere to porcine gastric mucin in vitro. Higher attachment was observed with Lactobacillus delbrueckii subsp. bulgaricus strains 6-8 and 8-1 than with Lactobacillus rhamnosus GG (positive control). Lactococcus lactis subsp. cremoris strain 7-1 adhered to mucin as effectively as did strain GG. Heat inactivation decreased the adhesive ability of strains 6-8 and 8-1 but did not affect strain 7-1. The adhesion of strains 6-8, 7-1 and 8-1 was significantly inhibited when the cells were pretreated with periodate and trypsin, indicating that proteinaceous and carbohydrate-like cell surface compounds are involved in the adhesion of these strains. The adhesion of strain 7-1 was affected by the type of carbohydrate present in the growth medium, being higher with fructose than with lactose, galactose or xylose as the carbon source. The sugar content of 7-1 cells grown on various carbohydrates was negatively correlated with its adhesive ability. We provide new probiotic candidate strains and new information regarding carbohydrate preference that influences lactic acid bacterial adhesion to mucin. [ABSTRACT FROM AUTHOR]

Abstract: Lactococcus lactis G50 is a candidate probiotic bacterium with immunomodulatory activity. We evaluated the suitability of strain G50 as orally administered probiotics on the basis of its resistance to simulated gastrointestinal (GI) stress, including the presence of lysozyme, low pH, and bile, carbohydrate preference, and bacterial cell surface composition in vitro. This strain survived GI stresses but its resistance to lysozyme was affected by the type of available carbohydrate in the growth medium; it was unaffected with lactose, xylose and galactose as the carbon source but was significantly lower for fructose, sucrose and glucose. The resistance of strain G50 to low pH was unaffected by carbon source. Resistance to bile was determined by two methods; growth and survival study and varied with carbon source. The growth of strain G50 with 0.3% bile was lowest in lactose-containing broth, higher in broth containing xylose or galactose, and highest in broth containing sucrose, glucose, or fructose. In contrast, the survival of cells after 3h incubation with 0.3% bile was highest for lactose. The hydrophobicity of bacterial cells, which can be related to epithelial adhesion in certain cases, was also highest for lactose. The fatty acid composition of cells grown on lactose differed from that of cells grown on other carbon sources. These results suggest that survival of strain G50 in the GI tract depends on the kinds of carbohydrates available. Carbohydrate preferences were observed for other strains of lactic acid bacteria under conditions of GI stress, and this preference varied with the strain and the type of GI stress. Careful consideration should be given to the selection of carbohydrates for in vitro testing of the survival of lactic acid bacteria in the GI tract. [ABSTRACT FROM AUTHOR]

Abstract: Leukotriene B4 (LTB4) is a lipid mediator associated with innate immune function. LTB4 is produced mainly by polymorphonuclear leukocytes and macrophages and plays important roles in host defense. However, LTB4 is also associated with inflammation, and excessive production of LTB4 can result in inflammation, allergic reactions, and carcinogenesis. Regulation of excessive LTB4 production may therefore assist in controlling these conditions. In this study, we investigated the capacity of 7 strains of lactic acid bacteria to inhibit LTB4 production by the murine macrophage cell line J774.1. All strains tested inhibited calcium ionophore (A23187)-stimulated LTB4 production in macrophages, but to varying extents. Lactobacillus helveticus Bc-10 exhibited the highest level of inhibitory activity. The inhibitory activity of strain Bc-10 was sustained after heat-killing and was observed in the intracellular cell-free extract prepared from this strain. This is the first report that intact lactic acid bacteria and their isolated cellular components can directly inhibit LTB4 production by macrophages, and provides a useful method to screen the inhibitory activity of lactic acid bacteria. This study also highlights the potential of the strain Bc-10 as a treatment option for the regulation of LTB4 production in vivo. [Copyright &y& Elsevier]